J B Chemicals & Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 964.65 | 957.47 | 825.30 |
| Operating Expense | 687.58 | 678.93 | 614.15 |
| Net Profit | 173.12 | 173.23 | 125.85 |
| Net Profit Margin | 17.95 | 18.09 | 15.25 |
| Earning Per Share | 11.15 | 11.16 | 8.11 |
| EBIDTA | 268.03 | 270.17 | 201.81 |
| Effective Tax Rate | 18.78 | 18.89 | 13.22 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 964.65 |
| Operating Expense | 687.58 |
| Net Profit | 173.12 |
| Net Profit Margin | 17.95 |
| Earning Per Share | 11.15 |
| EBIDTA | 268.03 |
| Effective Tax Rate | 18.78 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 3,298.64 | 2,884.16 | 2,189.88 |
| Operating Expenses Annual | 2,419.23 | 2,219.47 | 1,680.97 |
| Operating Profit Annual | 914.09 | 673.34 | 547.52 |
| Interest Annual | 40.52 | 34.31 | 4.95 |
| Depreciation | 135.24 | 111.99 | 71.28 |
| Net Profit Annual | 543.36 | 388.89 | 361.00 |
| Tax Annual | 194.98 | 138.15 | 110.29 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 3,298.64 |
| Operating Expenses Annual | 2,419.23 |
| Operating Profit Annual | 914.09 |
| Interest Annual | 40.52 |
| Depreciation | 135.24 |
| Net Profit Annual | 543.36 |
| Tax Annual | 194.98 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 53.88 | 37.69 | 24.26 |
| Cash Flow from Operations | 789.03 | 628.64 | 147.10 |
| Cash Flow from Investing | -412.47 | -955.86 | 4.18 |
| Cash Flow from Financing | -374.08 | 343.41 | -137.85 |
| Cash Flow at the End | 56.37 | 53.88 | 37.69 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 53.88 |
| Cash Flow from Operations | 789.03 |
| Cash Flow from Investing | -412.47 |
| Cash Flow from Financing | -374.08 |
| Cash Flow at the End | 56.37 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 27.71 | 23.35 | 25 |
| PBIT Margin (%) | 23.61 | 19.46 | 21.75 |
| PBT Margin (%) | 23.03 | 18.89 | 17.36 |
| Net PROFIT Margin (%) | 16.47 | 13.48 | 16.48 |
| Return On Networth / Equity (%) | 20.39 | 17.11 | 18.46 |
| Return On Networth /Employed (%) | 24.83 | 21.68 | 23.61 |
| Return On Assets (%) | 17.30 | 14.97 | 17.97 |
| Total Debt / Equity (X) | 0.17 | 0.13 | 0.02 |
| Asset Turnover Ratio (%) | 1.05 | 1.11 | 1.09 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 27.71 |
| PBIT Margin (%) | 23.61 |
| PBT Margin (%) | 23.03 |
| Net PROFIT Margin (%) | 16.47 |
| Return On Networth / Equity (%) | 20.39 |
| Return On Networth /Employed (%) | 24.83 |
| Return On Assets (%) | 17.30 |
| Total Debt / Equity (X) | 0.17 |
| Asset Turnover Ratio (%) | 1.05 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 1,938.16 | 1,832.40 | 1,208.44 |
| Total Current Assets Annual | 1,715.40 | 1,398.30 | 1,130.85 |
| Non Current Assets Annual | 2,198.24 | 2,071.85 | 1,407.21 |
| Total Shareholders Funds Annual | 2,886.26 | 2,442.48 | 2,103.67 |
| Total Assets Annual | 3,913.64 | 3,470.15 | 2,538.07 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 1,938.16 |
| Total Current Assets Annual | 1,715.40 |
| Non Current Assets Annual | 2,198.24 |
| Total Shareholders Funds Annual | 2,886.26 |
| Total Assets Annual | 3,913.64 |
EPS (INR)
Expected
11.24
Reported
11.24
Surprise
0.00%
Jun 2024
EPS beaten by 0.00%
Mar 2024
EPS beaten by 0.00%
Dec 2023
EPS beaten by 1.11%
